Vanguard Portfolio Management
COLL icon

Vanguard Portfolio Management’s Collegium Pharmaceutical COLL Stock Holding History

Vanguard Portfolio Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8M Buy
740,081
+59,700
+9% +$2.04M ﹤0.01% 1891
2026
Q1 		$22.5M Buy
+680,381
New +$28.8M ﹤0.01% 1865

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Portfolio Management's COLL Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Collegium Pharmaceutical (COLL) stake by 8.8% in Q2 2026, buying an estimated $2.04M and bringing the position to 740,081 shares worth $26.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Vanguard Portfolio Management first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Vanguard Portfolio Management held 740,081 shares of Collegium Pharmaceutical worth $26.8M as of Q2 2026.
  • Vanguard Portfolio Management bought 59,700 Collegium Pharmaceutical shares in Q2 2026, an estimated $2.04M.
  • Collegium Pharmaceutical made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1891 holding.
  • Vanguard Portfolio Management first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 277 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.